Heron Therapeutics, Inc. /De/ financial data

Symbol
HRTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
4242 Campus Point Court, Suite 200, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
AP PHARMA INC /DE/ (to 1/7/2014), ADVANCED POLYMER SYSTEMS INC /DE/ (to 4/6/2001)
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 228 % +3.55%
Quick Ratio 53.3 % -12.1%
Debt-to-equity -746 % -102%
Return On Equity 240 %
Return On Assets -37.2 % +39.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 151 M shares +26.3%
Common Stock, Shares, Outstanding 150 M shares +26.1%
Entity Public Float 120 M USD -58.1%
Common Stock, Value, Issued 1.5 M USD +26.1%
Weighted Average Number of Shares Outstanding, Basic 151 M shares +26.8%
Weighted Average Number of Shares Outstanding, Diluted 151 M shares +26.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 51.7 M USD -30.4%
Selling and Marketing Expense 57.9 M USD -27.8%
General and Administrative Expense 48.2 M USD +10.1%
Costs and Expenses 158 M USD -15.6%
Operating Income (Loss) -82.4 M USD +43.1%
Nonoperating Income (Expense) 56 K USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -81 M USD +46.4%
Earnings Per Share, Basic -0.55 USD/shares +58%
Earnings Per Share, Diluted -0.55 USD/shares +58%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.5 M USD -24.5%
Cash, Cash Equivalents, and Short-term Investments 71.5 M USD +19.2%
Accounts Receivable, after Allowance for Credit Loss, Current 65.3 M USD +27%
Inventory, Net 42.5 M USD -18.4%
Assets, Current 186 M USD +4.35%
Property, Plant and Equipment, Net 19.3 M USD -10.3%
Operating Lease, Right-of-Use Asset 4.79 M USD -32.2%
Other Assets, Noncurrent 7.88 M USD -44.2%
Assets 218 M USD -1.35%
Accounts Payable, Current 837 K USD -79.4%
Employee-related Liabilities, Current 7.65 M USD -19.6%
Liabilities, Current 75.4 M USD -3.24%
Operating Lease, Liability, Noncurrent 2.05 M USD -57.7%
Other Liabilities, Noncurrent 241 K USD 0%
Liabilities 252 M USD +8.33%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6 K USD -167%
Retained Earnings (Accumulated Deficit) -1.91 B USD -4.43%
Stockholders' Equity Attributable to Parent -33.8 M USD -195%
Liabilities and Equity 218 M USD -1.35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.52 M USD +61.8%
Net Cash Provided by (Used in) Financing Activities 54.1 M USD -27.9%
Net Cash Provided by (Used in) Investing Activities 1.28 M USD -96.5%
Common Stock, Shares Authorized 225 M shares 0%
Common Stock, Shares, Issued 150 M shares +26.1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.23 M USD -170%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 20.5 M USD -24.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 649 K USD
Deferred Tax Assets, Valuation Allowance 430 M USD +1.65%
Deferred Tax Assets, Gross 431 M USD +1.51%
Operating Lease, Liability 5.18 M USD -31.8%
Payments to Acquire Property, Plant, and Equipment 1.55 M USD -15.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -81 M USD +46.3%
Lessee, Operating Lease, Liability, to be Paid 5.5 M USD -34.2%
Property, Plant and Equipment, Gross 37.2 M USD +2.03%
Operating Lease, Liability, Current 3.14 M USD +13.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.14 M USD +3.56%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.14 M USD +3.56%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 318 K USD -58.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.1 M USD -27.5%
Deferred Tax Assets, Operating Loss Carryforwards 321 M USD +2.28%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2.5 M shares 0%
Unrecognized Tax Benefits 10.9 M USD -2.96%
Operating Lease, Payments 3 M USD +3.45%
Additional Paid in Capital 1.87 B USD +3.21%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 689 K USD -4.04%
Share-based Payment Arrangement, Expense 28.3 M USD -29.3%
Interest Expense 3.87 M USD +56.3%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%